UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 178

Sortiert nach

MicroRNAs in Parkinson's disease

Neurobiology of disease, 2012-05, Vol.46 (2), p.279-284

Mouradian, M. Maral

2012

Volltextzugriff (PDF)

Pathogenetic Contributions and Therapeutic Implications of Transglutaminase 2 in Neurodegenerative Diseases

International journal of molecular sciences, 2024-02, Vol.25 (4), p.2364

2024

Volltextzugriff (PDF)

Cytoprotective mechanisms of DJ-1 against oxidative stress through modulating ERK1/2 and ASK1 signal transduction

Redox biology, 2018-04, Vol.14, p.211-217

2018

Volltextzugriff (PDF)

Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates with ATG7/autophagy to suppress neurodegeneration

PLoS genetics, 2022-04, Vol.18 (4), p.e1010138-e1010138

2022

Volltextzugriff (PDF)

Nucleic Acid–Based Therapeutics for Parkinson’s Disease

Neurotherapeutics, 2019-04, Vol.16 (2), p.287-298

2019

Volltextzugriff (PDF)

Letter from the Editor-in-Chief: Growth of the Journal

Neurotherapeutics, 2019-10, Vol.16 (4), p.923-923

Mouradian, M. Maral

2019

Volltextzugriff (PDF)

Repression of α-synuclein expression and toxicity by microRNA-7

Proceedings of the National Academy of Sciences - PNAS, 2009-08, Vol.106 (31), p.13052-13057

2009

Volltextzugriff (PDF)

Striatal ΔFosB gene suppression inhibits the development of abnormal involuntary movements induced by L-Dopa in rats

Gene therapy, 2021-12, Vol.28 (12), p.760-770

2021

Volltextzugriff (PDF)

DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway

Human molecular genetics, 2012-07, Vol.21 (13), p.3013-3024

2012

Volltextzugriff (PDF)

Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson’s disease and DLB

Proceedings of the National Academy of Sciences - PNAS, 2018-12, Vol.115 (51), p.E12053-E12062

2018

Volltextzugriff (PDF)

Silica-coated magnetic-nanoparticle-induced cytotoxicity is reduced in microglia by glutathione and citrate identified using integrated omics

Particle and fibre toxicology, 2021-11, Vol.18 (1), p.42-24, Article 42

2021

Volltextzugriff (PDF)

Role of striatal ΔFosB in L-Dopa–induced dyskinesias of parkinsonian nonhuman primates

Proceedings of the National Academy of Sciences - PNAS, 2019-09, Vol.116 (37), p.18664-18672

2019

Volltextzugriff (PDF)

Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications

Pharmacology & therapeutics (Oxford), 2012-03, Vol.133 (3), p.392-410

2012

Volltextzugriff (PDF)

MicroRNA-7 protects against 1-methyl-4-phenylpyridinium-induced cell death by targeting RelA

The Journal of neuroscience, 2014-09, Vol.34 (38), p.12725-12737

2014

Volltextzugriff (PDF)

Mitochondrial localization of DJ-1 leads to enhanced neuroprotection

Journal of neuroscience research, 2009-01, Vol.87 (1), p.123-129

2009

Volltextzugriff (PDF)

The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stress

Redox biology, 2018-10, Vol.19, p.62-73

2018

Volltextzugriff (PDF)

Metabolome Changes in Cerebral Ischemia

Cells (Basel, Switzerland), 2020-07, Vol.9 (7), p.1630

2020

Volltextzugriff (PDF)

MicroRNA-7 Promotes Glycolysis to Protect against 1-Methyl-4-phenylpyridinium-induced Cell Death

The Journal of biological chemistry, 2015-05, Vol.290 (19), p.12425-12434

2015

Volltextzugriff (PDF)

Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease

Movement disorders, 2012-02, Vol.27 (2), p.284-288

2012

Volltextzugriff (PDF)

Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease

Journal of neuropathology and experimental neurology, 2018-02, Vol.77 (2), p.139-148

2018

Volltextzugriff (PDF)

Recent advances in the genetics and pathogenesis of Parkinson disease

Neurology, 2002-01, Vol.58 (2), p.179

Mouradian, M Maral

2002

Volltextzugriff (PDF)

MicroRNAs in neurodegenerative diseases and their therapeutic potential

Pharmacology & therapeutics (Oxford), 2012-02, Vol.133 (2), p.142-150

2012

Volltextzugriff (PDF)

Interaction of DJ-1 with Daxx Inhibits Apoptosis Signal-Regulating Kinase 1 Activity and Cell Death

Proceedings of the National Academy of Sciences - PNAS, 2005-07, Vol.102 (27), p.9691-9696

2005

Volltextzugriff (PDF)

Letter from the Editor-in-Chief: Neurotherapeutics’ Transition to Gold Open Access

Neurotherapeutics, 2023-10, Vol.20 (6), p.1427-1427

Mouradian, M. Maral

2023

Volltextzugriff (PDF)

Proteasome inhibition induces α-synuclein SUMOylation and aggregate formation

Journal of the neurological sciences, 2011-08, Vol.307 (1), p.157-161

2011

Volltextzugriff (PDF)

1 – 25 von 178

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(174)
Mit Volltextzugriff
(163)

Publikationsform

Artikel
(176)
Buchkapitel
(2)

Sprache

Englisch
(178)
Japanisch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

MicroRNAs in Parkinson's disease

Pathogenetic Contributions and Therapeutic Implications of Transglutaminase 2 in Neurodegenerative Diseases

Cytoprotective mechanisms of DJ-1 against oxidative stress through modulating ERK1/2 and ASK1 signal transduction

Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates with ATG7/autophagy to suppress neurodegeneration

Nucleic Acid–Based Therapeutics for Parkinson’s Disease

Letter from the Editor-in-Chief: Growth of the Journal

Repression of α-synuclein expression and toxicity by microRNA-7

Striatal ΔFosB gene suppression inhibits the development of abnormal involuntary movements induced by L-Dopa in rats

DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway

Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson’s disease and DLB

Silica-coated magnetic-nanoparticle-induced cytotoxicity is reduced in microglia by glutathione and citrate identified using integrated omics

Role of striatal ΔFosB in L-Dopa–induced dyskinesias of parkinsonian nonhuman primates

Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications

MicroRNA-7 protects against 1-methyl-4-phenylpyridinium-induced cell death by targeting RelA

Mitochondrial localization of DJ-1 leads to enhanced neuroprotection

The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stress

Metabolome Changes in Cerebral Ischemia

MicroRNA-7 Promotes Glycolysis to Protect against 1-Methyl-4-phenylpyridinium-induced Cell Death

Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease

Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease

Recent advances in the genetics and pathogenesis of Parkinson disease

MicroRNAs in neurodegenerative diseases and their therapeutic potential

Interaction of DJ-1 with Daxx Inhibits Apoptosis Signal-Regulating Kinase 1 Activity and Cell Death

Letter from the Editor-in-Chief: Neurotherapeutics’ Transition to Gold Open Access

Proteasome inhibition induces α-synuclein SUMOylation and aggregate formation

Suchergebnisse filtern